Danaher Co. (NYSE:DHR) Shares Bought by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC grew its holdings in Danaher Co. (NYSE:DHR) by 30.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 39,685 shares of the conglomerate’s stock after acquiring an additional 9,268 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Danaher were worth $3,944,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in DHR. GQG Partners LLC acquired a new stake in shares of Danaher in the 2nd quarter valued at approximately $101,000. Zions Bancorporation raised its holdings in Danaher by 118.3% during the third quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock worth $106,000 after purchasing an additional 667 shares during the last quarter. Patten Group Inc. raised its holdings in Danaher by 262.3% during the third quarter. Patten Group Inc. now owns 4,830 shares of the conglomerate’s stock worth $114,000 after purchasing an additional 3,497 shares during the last quarter. Monetary Management Group Inc. raised its holdings in Danaher by 10.7% during the second quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock worth $131,000 after purchasing an additional 150 shares during the last quarter. Finally, Acrospire Investment Management LLC raised its holdings in Danaher by 185.5% during the second quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock worth $143,000 after purchasing an additional 1,100 shares during the last quarter. Institutional investors own 76.19% of the company’s stock.

DHR has been the subject of several research reports. Morgan Stanley raised their price target on Danaher from $95.00 to $98.00 and gave the stock an “overweight” rating in a research report on Friday, October 20th. Argus lifted their price objective on Danaher from $100.00 to $115.00 and gave the company a “buy” rating in a research report on Thursday, February 1st. Credit Suisse Group lifted their price objective on Danaher from $93.00 to $96.00 and gave the company an “outperform” rating in a research report on Friday, October 20th. Citigroup boosted their price target on Danaher to $107.00 and gave the company a “buy” rating in a research report on Friday, December 15th. Finally, Robert W. Baird boosted their price objective on Danaher from $87.00 to $97.00 and gave the stock an “outperform” rating in a research note on Friday, October 20th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. Danaher has a consensus rating of “Buy” and an average target price of $100.13.

Shares of Danaher Co. (DHR) opened at $94.46 on Friday. Danaher Co. has a one year low of $78.97 and a one year high of $104.82. The stock has a market capitalization of $65,710.00, a P/E ratio of 26.99, a price-to-earnings-growth ratio of 1.99 and a beta of 1.04. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.39.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.16 by $0.03. The firm had revenue of $5.09 billion for the quarter, compared to analysts’ expectations of $4.97 billion. Danaher had a return on equity of 11.36% and a net margin of 13.60%. Danaher’s revenue for the quarter was up 10.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.05 earnings per share. equities research analysts expect that Danaher Co. will post 4.37 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Friday, December 29th were issued a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a dividend yield of 0.59%. The ex-dividend date was Thursday, December 28th. Danaher’s dividend payout ratio (DPR) is presently 16.00%.

In other news, SVP Angela S. Lalor sold 42,988 shares of the company’s stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $102.29, for a total transaction of $4,397,242.52. Following the completion of the transaction, the senior vice president now directly owns 82,008 shares of the company’s stock, valued at $8,388,598.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Daniel Raskas sold 37,870 shares of the stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $93.33, for a total value of $3,534,407.10. The disclosure for this sale can be found here. Insiders have sold 274,913 shares of company stock valued at $27,729,293 over the last ninety days. Corporate insiders own 12.20% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Danaher Co. (NYSE:DHR) Shares Bought by Wealth Enhancement Advisory Services LLC” was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright legislation. The correct version of this piece of content can be viewed at https://ledgergazette.com/2018/02/11/wealth-enhancement-advisory-services-llc-acquires-9268-shares-of-danaher-co-dhr.html.

About Danaher

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply